Basic Glucophage Sr Information

• INN (International Nonproprietary Name): Metformin hydrochloride (Metforminum hydrochloridum).
• Brand Names Available In United Kingdom: Not specified.
• ATC Code: A10BA02 — Metformin, classified under A10B (Blood glucose lowering drugs, excluding insulins), A10BA (Biguanides).
• Forms & Dosages: Extended‑release tablets 500 mg, 750 mg, 1000 mg; oral, once daily.
• Manufacturers In United Kingdom: Not specified.
• Registration Status In United Kingdom: Not specified.
• OTC / Rx Classification: Prescription Medicine (Rx only) in all major markets.

Take Glucophage SR (metformin hydrochloride extended‑release) only on a valid prescription and keep it in its original packaging at room temperature (15–30°C).

If you drive or work in safety‑sensitive roles, watch for dizziness or severe fatigue and report any new concerns to your GP or pharmacist.

Avoid excessive alcohol and tell staff before scans requiring iodinated contrast media.

Carry a list of medicines and recent eGFR results at all times.

If you suspect overdose or lactic acidosis (severe malaise, muscle pain, fast breathing), call 999 immediately.

What To Carry At All Times (Checklist):

• Current prescription or NHS repeat slip.
• List of medicines and doses.
• Most recent eGFR/renal result and date.
• GP or diabetes clinic contact details.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Glucophage SR is designed as a once‑daily extended‑release tablet available in 500 mg, 750 mg and 1000 mg strengths.

Many UK prescribers start adults on 500 mg with the evening meal and increase by 500 mg each week as tolerated.

Typical maintenance doses are 1500–2000 mg per day, with some brands licensed up to 2500 mg; always follow your prescriber’s advice.

Switching to breakfast is acceptable for patients who prefer morning dosing, provided it is tolerated and taken at the same time each day to aid adherence.

• Week 1: 500 mg once daily (evening meal).
• Week 2: 1000 mg once daily (evening meal) if tolerated.
• Week 3: 1500 mg once daily, then titrate up by 500 mg weekly as required.
• Maximum: Per product licence—commonly 2000 mg to 2500 mg daily; confirm with prescriber.

Taking With Or Without Meals (UK Diet Habits)

Taking Glucophage SR with food reduces early gastrointestinal effects such as nausea and diarrhoea.

For many UK patients who eat a larger evening meal, an evening dose often minimises daytime stomach upsets and supports steadier overnight glucose control.

If gastrointestinal symptoms persist during titration, ask your pharmacist about slower titration or dividing doses only if the prescriber advises doing so.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Do not use Glucophage SR if you have severe renal impairment (eGFR <30 mL/min/1.73 m²) or known hypersensitivity to metformin or excipients.

Avoid starting treatment if eGFR is between 30 and 45 mL/min/1.73 m² without specialist review.

Caution is advised in patients over 80 years unless renal function is confirmed normal.

Avoid use in significant hepatic disease or chronic alcohol misuse because of increased lactic acidosis risk.

Contraindications (Checklist):

• Severe renal impairment (eGFR <30).
• Acute metabolic acidosis or diabetic ketoacidosis.
• Ongoing tissue hypoxia (uncontrolled heart failure, shock).
• Alcoholism or heavy alcohol use.

Activities To Limit (Driving, Work Safety)

Metformin alone rarely causes hypoglycaemia, but combinations with insulin or sulfonylureas increase that risk.

Stop driving and tell your employer if you experience severe dizziness, fainting or profound fatigue.

For safety‑critical jobs (HGV drivers, pilots, heavy machinery), discuss workplace fitness and monitoring with your GP.

When To Stop Before Procedures (Checklist):

• Stop at the time of major surgery or per local NHS trust peri‑procedural guidance.
• Hold before certain radiological procedures involving iodinated contrast; follow local protocol and check eGFR before restarting.
• Pause during dehydration, severe infection or if renal function declines.

Dosage & Adjustments

General Regimen (NHS Guidance)

Adults commonly start on 500 mg once daily with food and increase by 500 mg each week as tolerated.

Most maintenance regimens fall between 1500 mg and 2000 mg daily, with maximum dose varying by formulation and product licence.

Check renal function before initiation and at least annually thereafter.

Special Cases (Elderly, Comorbidities)

Elderly patients require slow titration and closer renal monitoring; avoid initiating if eGFR <45 without specialist input.

Patients with heart failure, liver disease, heavy alcohol use or dehydration need careful review and consideration of alternatives.

Before contrast imaging or major surgery, hold metformin according to local NHS policy and reassess kidney function before restarting.

Renal Monitoring Checklist:

• Baseline eGFR before starting.
• At least annual review if stable.
• More frequent checks if eGFR 45–60 or other risks present.

User Testimonials

Positive Reports From UK Patients

“Switched from immediate release and now take one tablet at night — much less nausea,” says a typical poster on a UK forum.

Many patients report once‑daily dosing improves adherence and that slower absorption reduces daytime stomach upsets.

Community pharmacy teams at Boots and LloydsPharmacy often hear that users notice steadier morning readings when dosed with the evening meal.

Common Challenges (Patient.info, NHS Forums)

Initial diarrhoea or nausea during up‑titration is commonly reported and usually settles with slower increases.

Long‑term users sometimes worry about vitamin B12 depletion and request blood tests after years on therapy.

Confusion between SR and XR labelling across brands is a frequent forum topic; checking the INN (metformin hydrochloride) and tablet strength helps avoid mistakes.

Patient Tips (Bullet List):

• Ask for a slow titration if you had GI side effects before.
• Carry a copy of your prescription and recent eGFR while travelling.
• Label boxes clearly at home to avoid mixing SR and IR products.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Glucophage SR is a prescription‑only medication across the UK and should be obtained via your GP or diabetes clinic.

High‑street pharmacies such as Boots, LloydsPharmacy and Superdrug dispense branded SR or generic metformin SR according to prescription and stock availability.

Online pharmacies may dispense with a valid prescription and must be registered with the General Pharmaceutical Council.

Price Comparison (NHS Prescription Charge Vs Private)

Checklist Before Buying Online:

• Verify MHRA licence or manufacturer details on the pack.
• Confirm the pharmacy is registered with the General Pharmaceutical Council.
• Ensure a valid prescription will be required and checked.

In our online pharmacy, glucophage sr is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

What’s Inside & How It Works

Ingredients Overview

The active ingredient is metformin hydrochloride (INN: Metforminum hydrochloridum).

SR tablets contain excipients that vary by manufacturer; check the patient information leaflet for allergens and full composition.

Manufacturers in EU and global markets include Sanofi, Teva, STADA, Zentiva and others; packaging differs by country.

Mechanism Basics Explained Simply

Metformin lowers blood glucose mainly by reducing hepatic glucose production and improving insulin sensitivity in peripheral tissues.

It does not stimulate insulin secretion, so the risk of hypoglycaemia is low when used alone.

Classified as a biguanide (ATC A10BA02), SR formulations release drug slowly to reduce peak GI concentration and improve tolerability.

Active Vs Common Excipients:

• Active: Metformin hydrochloride.
• Excipients: Vary by brand — check leaflet for lactose or other allergens.

Practical Note: Do not double up doses after a missed tablet; consult your pharmacist if you miss more than one day.

Store at 15–30°C in the original blister or box and keep out of reach of children.

Main Indications

Approved Uses (MHRA Listing)

Glucophage SR is indicated as first‑line therapy for type 2 diabetes mellitus in adults in combination with diet and exercise to improve glycaemic control.

Treatment is typically chronic and reviewed regularly according to clinical response and renal function.

Off‑Label Uses In UK Clinics

Some UK specialists use metformin in metabolic syndrome management and certain cases of polycystic ovary syndrome (PCOS) with documented rationale.

It is not appropriate as monotherapy for type 1 diabetes.

When Prescribed (Bullet List):

• Newly diagnosed type 2 diabetes as part of lifestyle changes.
• Long‑term glycaemic control when tolerated.
• Considered by specialists for metabolic concerns or PCOS with clear justification.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

Alcohol increases the risk of lactic acidosis and should be limited; avoid binge drinking.

Strong coffee on an empty stomach may worsen gastrointestinal upset but there are no major interactions with normal tea or coffee intake.

Iron and some multivitamins can affect absorption timing; separate dosing when advised.

Drug Conflicts (MHRA Yellow Card Reports)

Discuss with your prescriber or pharmacist if you take nephrotoxic drugs such as NSAIDs or certain ACE inhibitors/ARBs, particularly if volume‑depleted.

Hold metformin before iodinated contrast procedures per local NHS protocol and check renal function before restarting.

Combining metformin with insulin or sulfonylureas can increase hypoglycaemia risk and requires monitoring.

Drugs To Discuss With Your Prescriber (Checklist):

• NSAIDs and diuretics if dehydrated.
• ACE inhibitors/ARBs with fluctuating renal function.
• Insulin and sulfonylureas for hypoglycaemia risk.
• Iodinated contrast media before imaging procedures.

Report suspected adverse reactions through the MHRA Yellow Card scheme; rare reports include lactic acidosis and renal function changes.

Latest Evidence & Insights

Key UK & EU Studies 2022–2025

Recent observational cohorts from UK primary care show similar glycaemic control between SR and immediate‑release formulations with fewer discontinuations for SR.

EU registry analyses indicate consistent cardiovascular benefit signals when metformin is started early and used in combination therapy.

Randomised trials comparing ER brands demonstrate equivalent HbA1c reductions and lower early GI adverse events with SR products.

Top Studies (Summary):

• 2022 UK primary care cohort — population on SR vs IR; takeaway: fewer discontinuations with SR.
• 2023 EU registry analysis — cardiovascular outcomes in early metformin users; takeaway: stable benefit signals.
• 2024 RCTs comparing extended‑release brands — takeaway: similar HbA1c, lower early GI events with SR.

UK trusts have refined peri‑contrast management policies and eGFR thresholds based on these and earlier data, emphasising personalised choice for adherence and tolerability.

Alternative Choices

NHS Prescribing Alternatives With Pros/Cons Checklist

When metformin is unsuitable, NHS options include DPP‑4 inhibitors (e.g. sitagliptin), SGLT2 inhibitors (dapagliflozin, empagliflozin), sulfonylureas and insulin depending on targets and comorbidities.

SGLT2 inhibitors offer cardiorenal benefits for appropriate patients, while DPP‑4 inhibitors are generally well tolerated in renal impairment with dose adjustments.

Pros/Cons Checklist:

• Metformin SR: pros — low hypoglycaemia risk, weight neutral; cons — GI effects, contraindicated in severe renal impairment.
• SGLT2 Inhibitors: pros — cardiorenal benefits, weight loss; cons — genital infections, cost.
• DPP‑4 Inhibitors: pros — well tolerated; cons — smaller HbA1c reduction.
• Sulfonylureas: pros — inexpensive; cons — hypoglycaemia and weight gain risk.

Choice depends on renal function, cardiovascular disease, cost and patient preference and is usually discussed during NHS long‑term condition reviews.

Regulation Snapshot

MHRA Approval & NHS Prescribing Framework

Glucophage SR (metformin hydrochloride sustained release) is a prescription‑only medicine recognised within EU and MHRA frameworks.

MHRA and EMA guidance align on contraindications such as eGFR thresholds and hepatic impairment and recommend adverse event reporting.

In Romania the product is listed by ANMDMR; in the USA XR formulations are FDA‑approved under Glucophage XR and generics.

What To Ask Your Prescriber (Checklist):

• Confirm eGFR baseline and monitoring schedule.
• Clarify when to hold metformin for procedures or contrast imaging.
• Discuss alternative options if renal or hepatic issues are present.

Pharmacies must dispense under prescription and online pharmacies must be registered with the General Pharmaceutical Council.

FAQ

Common UK Patient Questions

Q: Can I drive while on Glucophage SR?

A: Yes generally — metformin alone rarely causes hypoglycaemia, but stop driving if you experience severe dizziness, fainting or profound fatigue and report it to your GP.

Q: How often should my kidney function be checked?

A: Baseline before starting, then at least annually; check more frequently if eGFR is 45–60 or you have other risks.

Q: Is vitamin B12 testing necessary?

A: Consider baseline B12 and repeat testing if you develop anaemia or neuropathy, as long‑term use can be associated with B12 deficiency.

Q: Can I take it while pregnant or breastfeeding?

A: Discuss with your obstetric team — metformin is used in some pregnancy contexts but requires specialist advice and monitoring.

What To Tell Your Pharmacist:

• Your current dose and timing.
• Recent eGFR result and date.
• Any symptoms like persistent GI upset or numbness/tingling.

Guidelines For Proper Use

UK Pharmacist Counselling Style

Confirm the exact product and strength (Glucophage SR versus other SR brands) and review the patient’s most recent eGFR and blood tests.

Ask about gastrointestinal tolerability, alcohol intake and any symptoms suggesting B12 deficiency or lactic acidosis.

Advise on missed doses: take as soon as remembered unless close to the next dose and do not double up.

Offer printed leaflets and set up repeat dispensing or NHS electronic repeat services where available.

NHS Patient Support Advice

Register for practice diabetes reviews and attend structured education such as DESMOND or local equivalents.

Use NHS apps and practice portals to view blood results and request repeat prescriptions in plenty of time before travel.

If travelling, request a repeat prescription in advance and carry a summary card with dose, recent eGFR and clinician contact details.

Counselling Checklist:

• Confirm product name and strength.
• Review kidney function and blood tests.
• Explain storage and missed dose actions.
• Provide a template “carry‑card” with medicines and eGFR for patients to keep.

Delivery Across United Kingdom